US EditionFirst UK User Describes Experience with Neuralink Brain Chip
Neuralink's trial now includes 21 participants worldwide using implants to restore function for people with severe paralysis, showing promising early control of devices by thought.
- Sebastian Gomez-Pena, volunteer in the first UK trial, showed he can control a laptop cursor using the Neuralink chip linked to 1,024 electrodes implanted at University College London Hospital by Neuralink's R1 surgical robot.
- It's taken Neuralink nearly 20 years to develop its chip, electrode, robot and AI tools, with the mission to restore autonomy for those with unmet medical needs while larger clinical trials are required.
- Nerve signals travel via electrode threads around 10-times thinner than a human hair to the chip, with 4mm electrode insertion depth in the hand-movement brain area, while AI decoding software `learns` to interpret signals.
- One early UK user described the impact as life-changing, saying `It is a massive change in your life where you can suddenly no longer move any of your limbs`, while Neuralink has not published results in peer-reviewed scientific journals and declined interviews.
- Neuralink plans include the Blindsight augment to restore vision, while Elon Musk said a next-generation Neuralink implant with three times current capability is expected later this year.
6 Articles
6 Articles
Elon Musk Announces Timeline For Next-Gen Neuralink Implant With 3X Capability — 21 People Already Enrolled Worldwide
Neuralink has grown its human trials to 21 participants worldwide as Elon Musk confirms a next-generation brain implant with three times the current capabilities is set to debut later this year. Neuralink Expands Human Trials On Wednesday, Musk's brain-implant company said that it now has 21 participants enrolled in clinical trials across the globe. This marks a notable increase from the 12 people reported using the implants in September to cont…
Elon Musk’s Neuralink Reaches 21 Global Trial Participants; Billionaire Announces Next-Gen ‘Telepathy’ Implant and Vision-Restoring ‘Blindsight’ Launch | 🔬 LatestLY
Neuralink has enrolled 21 participants worldwide in its human brain-chip trials, up from 12 in 2024. Elon Musk said the Telepathy implant enables users with paralysis to control devices using thoughts. The trials focus on spinal injuries and ALS, with zero serious adverse events reported so far. 🔬 Elon Musk’s Neuralink Reaches 21 Global Trial Participants; Billionaire Announces Next-Gen ‘Telepathy’ Implant and Vision-Restoring ‘Blindsight’ Laun…
Elon Musk's brain implant company Neuralink said Wednesday it now has 21 participants enrolled in trials worldwide, marking two years since it officially began human testing. That's up from 12 people the company said in September had received its chips and were using them to control digital and physical devices with their thoughts. The implant is designed to help people with conditions such as spinal cord injury. The first patient has used it to…
Elon Musk's Neuralink Says It Has 21 Participants Enrolled in Trials
Elon Musk’s brain implant company Neuralink said on Wednesday it now has 21 total participants enrolled in trials worldwide, as it completes two years since it officially began testing on humans. This marks an increase from the 12 people the company in September said had received its chips and were using them to control digital and physical tools through thought. The implant is designed to help people with conditions such as a spinal cord injury…
Elon Musk's Neuralink company announced Wednesday that 21 volunteers worldwide are participating in clinical trials of its brain implant, marking the second anniversary of the start of human trials.
Coverage Details
Bias Distribution
- 40% of the sources lean Left, 40% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
